{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:11:22Z","timestamp":1787893882718,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.beem.2006.03.009","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T11:22:33Z","timestamp":1150197753000},"page":"281-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Pregnancy complications in PCOS"],"prefix":"10.1016","volume":"20","author":[{"given":"Roy","family":"Homburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2006.03.009_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","article-title":"Modern use of clomiphene citrate in induction of ovulation","volume":"3","author":"Kousta","year":"1997","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.beem.2006.03.009_bib2","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/oxfordjournals.humrep.a019182","article-title":"Incidence of spontaneous abortion in clomiphene pregnancies","volume":"11","author":"Dickey","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)36736-X","article-title":"Further clinical experience with clomiphene citrate","volume":"19","author":"Macgregor","year":"1968","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.03.009_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/deg177","article-title":"The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study","volume":"18","author":"Creus","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.1990.tb00491.x","article-title":"Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles","volume":"33","author":"Shoham","year":"1990","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2006.03.009_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-0528.1992.tb14470.x","article-title":"Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin","volume":"99","author":"Hamilton-Fairley","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.beem.2006.03.009_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0015-0282(16)55794-X","article-title":"Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovary syndrome","volume":"59","author":"Homburg","year":"1993","journal-title":"Fertililty and Sterility"},{"key":"10.1016\/j.beem.2006.03.009_bib8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.humrep.a138174","article-title":"Miscarriage rates following in-vitro fertilisation are increased in women with polycystic ovaries and reduced by pituitary desensitisation with buserelin","volume":"8","author":"Balen","year":"1993","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib9","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1093\/humrep\/17.12.3220","article-title":"Early pregnancy loss following assisted reproductive technology treatment","volume":"17","author":"Winter","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib10","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/humrep\/16.12.2606","article-title":"Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment","volume":"16","author":"Wang","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(16)58026-1","article-title":"Studies on the cytogenetic and endocrinologic background of spontaneous abortion","volume":"65","author":"Hasegawa","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.03.009_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/oby.2002.74","article-title":"Obesity increases the risk of spontaneous abortion during infertility treatment","volume":"10","author":"Wang","year":"2002","journal-title":"Obesity Research"},{"key":"10.1016\/j.beem.2006.03.009_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2005.04.021","article-title":"Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovarian syndrome","volume":"84","author":"Palomba","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.03.009_bib14","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasmonogen inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility and miscarriage","volume":"336","author":"Regan","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.03.009_bib16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1988","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2006.03.009_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bmj.297.6655.1027","article-title":"Recurrent early miscarriage and polycystic ovaries","volume":"297","author":"Sagle","year":"1988","journal-title":"British Medical Journal"},{"issue":"supplement 123","key":"10.1016\/j.beem.2006.03.009_bib18","article-title":"Abnormalities of follicular phase luteinising hormone secretion in women with recurrent early miscarriage","author":"Watson","year":"1989","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.03.009_bib19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0015-0282(16)56287-6","article-title":"In-vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome","volume":"60","author":"Homburg","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.03.009_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1471-0528.1993.tb15214.x","article-title":"Laparoscopic ovarian diathermy: an effective treatment for anti-oestrogen resistant anovulatory infertility in women with the polycystic ovary syndrome","volume":"100","author":"Armar","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.beem.2006.03.009_bib21","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vacularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","author":"Diamantis-Kandarakis","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.03.009_bib23","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1210\/jc.2005-0965","article-title":"Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study","volume":"90","author":"Orio","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib26","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib27","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/jc.2004-0689","article-title":"Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate resistant women with polycystic ovary syndrome: A prospective parallel randomized double-blind placebo-controlled trial","volume":"89","author":"Palomba","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib28","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","article-title":"Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome","volume":"90","author":"Palomba","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib29","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.03.009_bib31","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss results in significant improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0950-3552(98)80051-5","article-title":"Adverse effect of luteinizing hormone on fertility: fact or fantasy","volume":"12","author":"Homburg","year":"1996","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"10.1016\/j.beem.2006.03.009_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0015-0282(16)58569-0","article-title":"The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with FSH in PCOS, a randomized study","volume":"66","author":"Van der Meer","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.03.009_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.humrep.a137035","article-title":"Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries","volume":"5","author":"Homburg","year":"1990","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib35","first-page":"501","article-title":"Pregnancy in infertile PCOD patients. Complications and outcome","volume":"42","author":"Urman","year":"1997","journal-title":"The Journal of Reproductive Medicine"},{"key":"10.1016\/j.beem.2006.03.009_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000067719","article-title":"Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome","volume":"54","author":"Bjercke","year":"2002","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1016\/j.beem.2006.03.009_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/humrep\/16.2.226","article-title":"Obstetric outcome in women with polycystic ovary syndrome","volume":"16","author":"Mikola","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/09513590400007242","article-title":"Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome","volume":"19","author":"Weerakiet","year":"2004","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.beem.2006.03.009_bib39","first-page":"194","article-title":"Impaired glucose tolerance in pregnant women with polycystic ovary syndrome","volume":"94","author":"Radon","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2006.03.009_bib40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem.83.4.4707","article-title":"High prevalence of polycystic ovaries and associated clinical, endocrine and metabolic features in women with previous gestational diabetes mellitus","volume":"83","author":"Holte","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2000.01123.x","article-title":"The prevalence of polycystic ovaries in women with a history of gestational diabetes","volume":"53","author":"Kousta","year":"2000","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2006.03.009_bib42","first-page":"2591","article-title":"Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes","volume":"86","author":"Koivunen","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0029-7844(98)00133-1","article-title":"Polycystic ovaries in women with geatational diabetes","volume":"92","author":"Anttila","year":"1998","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2006.03.009_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0020-7292(03)00003-1","article-title":"Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients","volume":"81","author":"Turhan","year":"2003","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1016\/j.beem.2006.03.009_bib45","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/humrep\/deg289","article-title":"Pregnancy outcome in women with PCOS and in controls matched by age and weight","volume":"18","author":"Haakova","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib46","first-page":"991","article-title":"Polycystic ovary disease and the risk of pregnancy-induced hypertension","volume":"45","author":"Kashyap","year":"2000","journal-title":"The Journal of Reproductive Medicine"},{"key":"10.1016\/j.beem.2006.03.009_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0028-2243(82)90097-1","article-title":"High incidence of preeclamptic toxemia in patients with polycystic ovarian disease","volume":"14","author":"Diamant","year":"1982","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"key":"10.1016\/j.beem.2006.03.009_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/10641959909009612","article-title":"Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and\/or preeclampsia","volume":"18","author":"Fridstrom","year":"1999","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.beem.2006.03.009_bib49","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth","volume":"83","author":"Ibanez","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.03.009_bib50","first-page":"707","article-title":"Prevalence of metaboli c disorders among family members of patients with polycystic ovary syndrome","volume":"129","author":"Benitez","year":"2001","journal-title":"Revista Medica de Chile"},{"key":"10.1016\/j.beem.2006.03.009_bib51","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.ijo.0802301","article-title":"Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms","volume":"27","author":"Laitinen","year":"2003","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.beem.2006.03.009_bib52","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/dei009","article-title":"Birth weight in offspring of mothers with polycystic ovarian syndrome","volume":"20","author":"Sir-Petermann","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.03.009_bib53","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(98)07546-1","article-title":"The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular diseases","volume":"353","author":"Hattersley","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.03.009_bib54","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(86)91340-1","article-title":"Infant mortality, chidhood nutrition and ischaemic heart disease in England and Wales","volume":"i","author":"Barker","year":"1986","journal-title":"Lancet"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:36:42Z","timestamp":1761496602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X06000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1521690X06000303"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2006.03.009","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy complications in PCOS","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2006.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}